Repligen
RGEN
#1858
Rank
A$16.07 B
Marketcap
A$251.51
Share price
2.97%
Change (1 day)
12.20%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2026 (TTM): A$0.11 Billion

According to Repligen 's latest financial reports the company's current earnings are A$0.78 Billion. In 2025 the company made an earning of A$0.12 Billion, an increase over its 2024 earnings that were of -A$9.14 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.11 B-9.48%
2025 A$0.12 B-1430.84%
2024 -A$9.14 Million-113.01%
2023 A$70.23 M-78.01%
2022 A$0.31 B33.37%
2021 A$0.23 B131.52%
2020 A$0.10 B101.31%
2019 A$51.38 M25.93%
2018 A$40.8 M105.61%
2017 A$19.84 M-11.46%
2016 A$22.41 M14.91%
2015 A$19.5 M20.26%
2014 A$16.21 M-51.49%
2013 A$33.43 M90.98%
2012 A$17.5 M
2010 A$0.25 M-103.81%
2009 -A$6.66 Million-223.84%
2008 A$5.37 M
2006 -A$3.61 Million229.64%
2005 -A$1.1 Million-89.16%
2004 -A$10.1 Million-16.86%
2003 -A$12.15 Million88.72%
2002 -A$6.44 Million-27.88%
2001 -A$8.93 Million-1.74%
2000 -A$9.09 Million85.93%
1999 -A$4.89 Million159.16%
1998 -A$1.89 Million85.71%
1997 -A$1.02 Million-70.83%
1996 -A$3.48 Million-72.41%
1995 -A$12.62 Million-60.63%
1994 -A$32.04 Million45.39%
1993 -A$22.04 Million39.45%
1992 -A$15.81 Million-32.3%
1991 -A$23.35 Million6.62%
1990 -A$21.9 Million1577.78%
1989 -A$1.31 Million-57.14%
1988 -A$3.05 Million-362.5%
1987 A$1.15 M-130.77%
1986 -A$3.77 Million136.36%
1985 -A$1.6 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.01 B 9,196.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$11.07 B 10,178.60%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$17.02 B 15,708.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.42 B 15,151.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-A$0.16 Billion-248.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-A$0.33 Billion-400.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$1.18 B 1,001.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$0.36 B 236.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.21 B 100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-A$0.27 Billion-347.20%๐Ÿ‡บ๐Ÿ‡ธ USA